Workflow
更年期健康管理
icon
Search documents
更年期别硬“熬”,笑迎人生新阶段
Xin Lang Cai Jing· 2026-01-16 18:02
Core Viewpoint - There are approximately 210 million perimenopausal women in China, with 80% experiencing significant menopausal symptoms, yet very few actively seek medical help. Misconceptions such as "just wait it out" or "no need to fuss after menopause" are causing women to miss critical health management opportunities [2] Group 1: Understanding Menopause - Menopause is not exclusively for women over 45; it can occur as early as 30 due to ovarian function decline, which is not strictly age-related [2][3] - The primary signal of ovarian function decline is changes in menstrual cycles, such as a shortening of the cycle from about 28 days to 23-25 days for over six months, indicating a decrease in ovarian reserve [3] Group 2: Health Risks Associated with Menopause - The risk of osteoporosis increases significantly post-menopause, with a yearly bone mass loss rate of 3%-5%, leading to higher chances of fractures [5] - Cardiovascular risks also rise due to estrogen deficiency, which can lead to hypertension, hyperlipidemia, and increased probabilities of serious events like coronary heart disease and stroke [5] Group 3: Management Strategies - Regular health check-ups are essential for women over 40, including monitoring blood pressure, blood sugar, blood lipids, and bone density [8] - Dietary adjustments should focus on whole grains, vegetables, and fruits, with specific limits on sugar, oil, and salt intake [8][9] - Engaging in regular moderate-intensity aerobic exercise for at least 150 minutes weekly, combined with resistance training, is recommended to enhance bone and muscle strength [9] Group 4: Hormone Therapy Misconceptions - There are common misconceptions about hormone therapy, such as equating it with corticosteroids, which is incorrect as menopause hormone therapy uses natural estrogen and progesterone [10] - The treatment dosage is significantly lower than normal ovarian secretion levels, making it safe with low adverse reaction rates when monitored properly [10] - Timing is crucial for starting hormone therapy; it is most effective when initiated within 10 years of menopause or before age 60 [11]
雅培进博会展台举办女性健康研讨会 聚焦生育力保护与更年期健康管理
Zheng Quan Ri Bao Wang· 2025-11-10 06:42
Group 1 - Abbott hosted a seminar on women's health management during the 8th China International Import Expo, focusing on fertility protection and menopause health management [1] - The National Health Commission emphasized the importance of improving reproductive health services to enhance birth quality and public happiness [1] - Experts recommend that women with fertility plans undergo scientific assessments and seek support when facing physiological challenges, with 60% of infertility patients able to conceive naturally through standardized treatment [1] Group 2 - The aging population in China is leading to increased attention on menopause health management, with over 280 million women expected to enter menopause by 2030 [2] - Decreased estrogen and progesterone levels during menopause can lead to various symptoms and increased risks of chronic diseases such as osteoporosis and cardiovascular issues [2] - Menopause management is crucial for women's long-term health, with lifestyle adjustments and medical interventions like hormone therapy available to alleviate symptoms and improve quality of life [2]
雅培进博展台举办女性健康研讨会,聚焦生育力保护与更年期管理
Bei Ke Cai Jing· 2025-11-08 09:48
Core Viewpoint - Abbott hosted a seminar focusing on women's health management throughout their life cycle, emphasizing fertility protection and menopause health management, advocating for the establishment of a fertility-friendly society [1][4]. Group 1: Fertility and Reproductive Health - The National Health Commission emphasizes the need for a fertility-friendly society and improved reproductive health services to enhance population quality and happiness [2]. - The infertility rate in China has risen to 17.6%, with hormonal balance being crucial for normal physiological functions [5]. - Experts recommend early fertility assessments for women planning to conceive, especially as the average age of first childbirth approaches 30 [5][7]. Group 2: Menopause Management - By 2030, over 280 million women in China are expected to enter menopause, necessitating effective health management strategies [11]. - Hormonal changes during menopause can lead to various health issues, including osteoporosis and cardiovascular diseases, highlighting the importance of menopause management [11]. - Early initiation of hormone replacement therapy (HRT) during menopause can provide protective benefits for cardiovascular and bone health [11][12]. Group 3: Collaborative Health Management - A comprehensive approach involving individuals, families, healthcare institutions, and society is essential for effective women's health management across all life stages [13]. - Establishing fertility-friendly hospitals and enhancing menopause outpatient services are recommended measures to safeguard women's health rights [13].
破局更年之困,共筑健康生态——以岭药业携手京东健康启动深化合作,共推更年期健康管理新篇章
Jiang Nan Shi Bao· 2025-08-20 05:43
Core Insights - The collaboration between Yiling Pharmaceutical and JD Health aims to enhance the "Anti-Aging Center" digital marketing initiative, leveraging both companies' strengths in their respective fields [1][2] Group 1: Collaboration Details - The partnership focuses on utilizing JD Health's platform traffic and digital marketing capabilities to create a comprehensive platform for expert education, authoritative information, and anti-aging resources [2] - Yiling Pharmaceutical will leverage its expertise in traditional Chinese medicine (TCM) research and product development, particularly promoting its core product, the Eight Sons Kidney Capsule [2][3] Group 2: Product Focus and Market Strategy - The collaboration will emphasize the unique benefits of the Eight Sons Kidney Capsule, particularly in women's health, addressing menopausal symptoms, and promoting a youthful appearance [2][3] - Both companies will conduct real-world studies and data analysis to reinforce Yiling Pharmaceutical's position as a leader in the scientific and data-driven TCM field [3] Group 3: Future Vision and Goals - The partnership is seen as a significant step towards digital transformation for Yiling Pharmaceutical, aiming to provide precise and scientific health solutions for women [4] - The collaboration aligns with the "Healthy China 2030" strategy, focusing on menopause health management and enhancing the overall health service ecosystem [4]